Observation of a high co-expression of sst5 and D2 in the majority of human corticotroph adenomas studied supports the potential for this agent in the treatment of Cushing's disease; clinical evaluation has not yet been performed [72]. The gene discussed is SSTR5; the disease is ACTH-producing pituitary gland adenoma.